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Why Do the Study?
To Err is Human: Building a Safer
Healthcare System*




Report issued by the Institute of Medicine in
late 1999
Highlighted the alarming frequency of ME

*Source: http:// www.iom.edu

Implications of To Err
Outlined a series of broad policy
recommendations to improve patient
safety & reduce medical error which
includes ME
Call to action for state and federal
agencies regarding ME

KY Board of Pharmacy Response
Concerned about KY Pharmacists’
contributions to the error statistics
Appointed a Statewide ME Task Force



Analyze the current status of ME in KY
Evaluate the KY Board’s response to ME

Task Force Considerations
Historically, the KY Board




Imposed actions on individual pharmacist in the
event of ME
Provided no clear guidance on or consideration
of ME Prevention (QA) programs

Expert Counsel



System failures responsible for most ME
QA programs within organizations key

Task Force Consensus
Important to first examine systems in
which pharmacists are functioning
Report to BOP in terms of guidance in
regards to ME and patient safety

Study Aims
Determine pharmacists perceptions on:
zFactors most associated with ME
zPresence of ME tracking systems
zMost common types of ME

Determine if there is a difference between
perceptions of Hospital vs. Community
pharmacists
z HO: ų1 = ų2

Study Results
Industry
<1%

Academia
1%

3511 surveys mailed

Other
8%

Hospital
18%

z 34.1% response rate
(n=1198)

Chain
43%

z 87.4% (n=918) were
Hospital or Community
pharmacists

Independent
26%
LTC
4%

Male
57%

Female
43%

What are the Most Common
Causes/Types of Medication Errors?
Perceptions from both groups indicate:






Poor Handwriting
Prescription Volume
Pharmacist Overwork
Pharmacist Fatigue
Noise, Distractions or Interruptions

Most Common Types of ME


Technical in nature
zIncorrect medicine, Incorrect Strength, Wrong
Patient

Factors Associated w/ME: Practically
Significant?

Insurance
Processing
Factor Assessed

Presence of ME Tracking Systems
KY law requires pharmacist-in-charge to
implement and maintain QA Programs
(ME Tracking/Reporting Systems)
Over 90% of pharmacists in both groups
felt that the risk of ME is increasing

Are ME Tracking Systems in
Place?
Only 80% of community pharmacists
perceive they have such systems in place
95% of hospital pharmacists perceive they
do as well
P-value = <0.001

Implications of these Findings
Three most common types of ME are
technical in nature as opposed to
knowledge deficiencies
Supports the expert panels’ position that
most ME are due to system failures

Implications of Findings continued
The goal should be and the mandate is
that 100% of pharmacies at least have a
ME tracking system in place


Learning from ME begins with reporting them

In this regard, the findings suggest:




KY BOP does not provide enough guidance
for meaningful QA in pharmacies
Hesitancy: current mandate does not protect
ME data from discovery in court of law

Recommendations
I.

Re-evaluate 201 KAR 2:225 (QA in
pharmacies)
a)
b)

II.

Include peer review protection
Provide sufficient detail for meaningful programs

Re-examine Board procedures that currently
classify ME as unprofessional conduct
a)
b)

Consider presence of QA when acting on a ME
case
Actively educate pharmacists on importance of QA
via continuing education programs, periodic
newsletter and inspections

Questions?

